146 related articles for article (PubMed ID: 25599647)
1. Lack of association between the CDH1 polymorphism and gastric cancer susceptibility: a meta-analysis.
Jiang B; Zhu K; Shao H; Bao C; Ou J; Sun W
Sci Rep; 2015 Jan; 5():7891. PubMed ID: 25599647
[TBL] [Abstract][Full Text] [Related]
2. [Correlation of E-cadherin polymorphisms to esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma].
Zhang XF; Wang YM; Wang R; Wei LZ; Li Y; Guo W; Wang N; Zhang JH
Ai Zheng; 2005 May; 24(5):513-9. PubMed ID: 15890089
[TBL] [Abstract][Full Text] [Related]
3. Association of CDH1 haplotypes with susceptibility to sporadic diffuse gastric cancer.
Humar B; Graziano F; Cascinu S; Catalano V; Ruzzo AM; Magnani M; Toro T; Burchill T; Futschik ME; Merriman T; Guilford P
Oncogene; 2002 Nov; 21(53):8192-5. PubMed ID: 12444556
[TBL] [Abstract][Full Text] [Related]
4. CDH1 C-160A promoter polymorphism and gastric cancer risk.
Corso G; Berardi A; Marrelli D; Pedrazzani C; Garosi L; Pinto E; Roviello F
Eur J Cancer Prev; 2009 Feb; 18(1):46-9. PubMed ID: 19077564
[TBL] [Abstract][Full Text] [Related]
5. Association of genetic variants in and promoter hypermethylation of CDH1 with gastric cancer: a meta-analysis.
Jing H; Dai F; Zhao C; Yang J; Li L; Kota P; Mao L; Xiang K; Zheng C; Yang J
Medicine (Baltimore); 2014 Oct; 93(19):e107. PubMed ID: 25340495
[TBL] [Abstract][Full Text] [Related]
6. A meta-analysis of CDH1 C-160A genetic polymorphism and gastric cancer risk.
Cui Y; Xue H; Lin B; Ni P; Fang JY
DNA Cell Biol; 2011 Nov; 30(11):937-45. PubMed ID: 21612411
[TBL] [Abstract][Full Text] [Related]
7. Single nucleotide polymorphisms in the promoter region of the E-cadherin gene in gastric cancer: case-control study in a young Mexican population.
Medina-Franco H; Ramos-De la Medina A; Vizcaino G; Medina-Franco JL
Ann Surg Oncol; 2007 Aug; 14(8):2246-9. PubMed ID: 17549573
[TBL] [Abstract][Full Text] [Related]
8. CDH1 polymorphisms and haplotypes in sporadic diffuse and intestinal gastric cancer: a case-control study based on direct sequencing analysis.
Chu CM; Chen CJ; Chan DC; Wu HS; Liu YC; Shen CY; Chang TM; Yu JC; Harn HJ; Yu CP; Yang MH
World J Surg Oncol; 2014 Mar; 12():80. PubMed ID: 24684952
[TBL] [Abstract][Full Text] [Related]
9. Association between CDH1 haplotypes and gastric cancer risk in a Japanese population.
Yamada H; Shinmura K; Ikeda S; Tao H; Otani T; Hanaoka T; Tsuneyoshi T; Tsugane S; Sugimura H
Scand J Gastroenterol; 2007 Dec; 42(12):1479-85. PubMed ID: 17852867
[TBL] [Abstract][Full Text] [Related]
10. Roles of E-cadherin (CDH1) genetic variations in cancer risk: a meta-analysis.
Deng QW; He BS; Pan YQ; Sun HL; Xu YQ; Gao TY; Li R; Song GQ; Wang SK
Asian Pac J Cancer Prev; 2014; 15(8):3705-13. PubMed ID: 24870781
[TBL] [Abstract][Full Text] [Related]
11. CDH1 c-160a promotor polymorphism is not associated with risk of stomach cancer.
Pharoah PD; Oliveira C; Machado JC; Keller G; Vogelsang H; Laux H; Becker KF; Hahn H; Paproski SM; Brown LA; Caldas C; Huntsman D
Int J Cancer; 2002 Sep; 101(2):196-7. PubMed ID: 12209998
[TBL] [Abstract][Full Text] [Related]
12. Lack of association between CDH1 C-160A genetic polymorphism and gastric cancer risk among Asian population.
Pan F; Tian J; Zhang Y; Pan Y
DNA Cell Biol; 2012 Mar; 31(3):275-6; author reply 277-9. PubMed ID: 22142022
[No Abstract] [Full Text] [Related]
13. Role of CDH1 promoter polymorphism and DNA methylation in bladder carcinogenesis: a meta-analysis.
Wang Y; Kong CZ; Zhang Z; Yang CM; Li J
DNA Cell Biol; 2014 Apr; 33(4):205-16. PubMed ID: 24491043
[TBL] [Abstract][Full Text] [Related]
14. CDH1 -160C>A gene polymorphism is an ethnicity-dependent risk factor for gastric cancer.
Chen B; Zhou Y; Yang P; Liu L; Qin XP; Wu XT
Cytokine; 2011 Aug; 55(2):266-73. PubMed ID: 21570316
[TBL] [Abstract][Full Text] [Related]
15. The E-cadherin (CDH1) -C160A polymorphism and colorectal cancer susceptibility: a meta-analysis.
Geng P; Chen Y; Ou J; Yin X; Sa R; Liang H
DNA Cell Biol; 2012 Jun; 31(6):1070-7. PubMed ID: 22339265
[TBL] [Abstract][Full Text] [Related]
16. E-cadherin gene C-160A promoter polymorphism and risk of non-cardia gastric cancer in a Chinese population.
Lu Y; Xu YC; Shen J; Yu RB; Niu JY; Guo JT; Hu X; Shen HB
World J Gastroenterol; 2005 Jan; 11(1):56-60. PubMed ID: 15609397
[TBL] [Abstract][Full Text] [Related]
17. CDH1 C-160A polymorphism and gastric cancer risk: evidence needed for clarification.
Zhang T; Zhao Z; Cao X; Yao Q
DNA Cell Biol; 2012 Mar; 31(3):272; author reply 273-4. PubMed ID: 22066580
[No Abstract] [Full Text] [Related]
18. The E-cadherin (CDH1) -160C>A polymorphism associated with gastric cancer among Asians but not Europeans.
Wang Q; Gu D; Wang M; Zhang Z; Tang J; Chen J
DNA Cell Biol; 2011 Jun; 30(6):395-400. PubMed ID: 21214416
[TBL] [Abstract][Full Text] [Related]
19. The association between miR-146a gene rs2910164 polymorphism and gastric cancer risk: a meta-analysis.
Fu B; Song P; Lu M; Wang B; Zhao Q
Biomed Pharmacother; 2014 Oct; 68(8):923-8. PubMed ID: 25455160
[TBL] [Abstract][Full Text] [Related]
20. Correlation of a single nucleotide polymorphism in the E-cadherin gene promoter with tumorigenesis and progression of gastric carcinoma in Japan.
Kuraoka K; Oue N; Yokozaki H; Kitadai Y; Ito R; Nakayama H; Yasui W
Int J Oncol; 2003 Aug; 23(2):421-7. PubMed ID: 12851691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
